Detalhe da pesquisa
1.
Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema.
Allergy Asthma Proc
; 38(3): 216-221, 2017 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28441992
2.
Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitor.
Ann Allergy Asthma Immunol
; 117(5): 508-513, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27788880
3.
Effect of reversal of neuromuscular blockade with sugammadex versus usual care on bleeding risk in a randomized study of surgical patients.
Anesthesiology
; 121(5): 969-77, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25208233
4.
Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: Findings from an international patient registry.
Ann Allergy Asthma Immunol
; 118(1): 110-112, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27865714
5.
Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes.
BMC Endocr Disord
; 10: 7, 2010 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-20412573
6.
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis.
BMC Endocr Disord
; 8: 14, 2008 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-18954434
7.
Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic children.
Pediatr Pulmonol
; 42(9): 838-43, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17659605
8.
Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes.
Diabetes Care
; 29(12): 2632-7, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17130196
9.
Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema.
Allergy Rhinol (Providence)
; 8(1): 13-19, 2017 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28381322
10.
Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert® (C1-INH) Registry.
Drugs Aging
; 33(11): 819-827, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27699634
11.
Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data.
J Allergy Clin Immunol Pract
; 4(5): 963-71, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27286778
12.
Efficacy and safety of sitagliptin added to ongoing metformin and rosiglitazone combination therapy in a randomized placebo-controlled 54-week trial in patients with type 2 diabetes.
J Diabetes
; 5(1): 68-79, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22742523
13.
Lower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: a pre-specified analysis adjusting for the most recently measured HbA(1c) value.
Curr Med Res Opin
; 28(8): 1281-7, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22697277
14.
Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients.
J Allergy Clin Immunol Pract
; 5(4): 1142-1145, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28286153
15.
Sitagliptin more effectively achieves a composite endpoint for A1C reduction, lack of hypoglycemia and no body weight gain compared with glipizide.
Diabetes Res Clin Pract
; 93(1): e15-7, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21477878
16.
Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Curr Med Res Opin
; 27(5): 1049-58, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21428727
17.
Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study.
Curr Med Res Opin
; 25(3): 569-83, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19232032
18.
Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes.
Diabetes Care
; 30(8): 1979-87, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17485570
19.
Efficacy of montelukast for treating perennial allergic rhinitis.
Allergy Asthma Proc
; 28(3): 296-304, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17619558